Raghuram Selvaraju
Stock Analyst at HC Wainwright & Co.
(1.95)
# 1,637
Out of 4,412 analysts
565
Total ratings
35.66%
Success rate
n/a
Average return
Main Sectors:
90 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals | Initiates: Buy | $8 | $2.15 | +272.09% | 1 | Apr 25, 2024 | |
| GANX Gain Therapeutics | Reiterates: Buy | $9 | $3.03 | +197.03% | 10 | Apr 25, 2024 | |
| ENLV Enlivex Therapeutics | Reiterates: Buy | $7 | $1.44 | +386.11% | 9 | Apr 23, 2024 | |
| BTAI BioXcel Therapeutics | Reiterates: Buy | $10 | $2.63 | +280.23% | 29 | Apr 23, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $100 | $42.49 | +135.35% | 18 | Apr 23, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $20 | $2.99 | +568.90% | 11 | Apr 22, 2024 | |
| URGN UroGen Pharma | Reiterates: Buy | $54 | $14.15 | +281.63% | 16 | Apr 18, 2024 | |
| MBOT Microbot Medical | Maintains: Buy | $8 → $7 | $0.88 | +695.45% | 5 | Apr 16, 2024 | |
| ONCT Oncternal Therapeutics | Maintains: Buy | $30 → $28 | $8.29 | +237.76% | 9 | Apr 15, 2024 | |
| INDP Indaptus Therapeutics | Reiterates: Buy | $12 | $2.44 | +391.80% | 10 | Apr 15, 2024 | |
| RAPT RAPT Therapeutics | Reiterates: Neutral | n/a | $8.10 | - | 16 | Apr 10, 2024 | |
| RKDA Arcadia Biosciences | Reiterates: Buy | $10 | $2.09 | +378.47% | 10 | Apr 5, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Buy | $4 | $1.16 | +244.83% | 2 | Apr 5, 2024 | |
| AQST Aquestive Therapeutics | Reiterates: Buy | $9 | $4.07 | +121.13% | 13 | Apr 5, 2024 | |
| GMAB Genmab | Reiterates: Buy | $50 | $28.15 | +77.62% | 28 | Apr 4, 2024 | |
| COCP Cocrystal Pharma | Reiterates: Buy | $10 | $1.56 | +543.09% | 12 | Apr 4, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $17 → $18 | $9.21 | +95.44% | 8 | Apr 4, 2024 | |
| ANVS Annovis Bio | Maintains: Buy | $30 | $18.01 | +66.57% | 10 | Apr 2, 2024 | |
| EQ Equillium | Maintains: Buy | $4 → $5 | $1.71 | +192.40% | 8 | Apr 2, 2024 | |
| ENTX Entera Bio | Maintains: Buy | $10 | $1.98 | +405.05% | 8 | Apr 2, 2024 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 | $71.71 | +164.96% | 18 | Apr 2, 2024 | |
| LABP Landos Biopharma | Downgrades: Neutral | $50 → $20 | $22.31 | -8.47% | 2 | Apr 1, 2024 | |
| ADMA ADMA Biologics | Reiterates: Buy | $6 → $7.5 | $6.55 | +14.50% | 12 | Mar 26, 2024 | |
| RMTI Rockwell Medical | Maintains: Buy | $11 → $9 | $1.46 | +518.56% | 16 | Mar 25, 2024 | |
| RGLS Regulus Therapeutics | Reiterates: Buy | $9 | $2.42 | +271.90% | 9 | Mar 25, 2024 | |
| FATE Fate Therapeutics | Reiterates: Neutral | $7 | $3.80 | +84.21% | 2 | Mar 19, 2024 | |
| SPRO Spero Therapeutics | Reiterates: Buy | $7 | $1.46 | +379.45% | 12 | Mar 18, 2024 | |
| TRDA Entrada Therapeutics | Reiterates: Buy | $20 | $12.45 | +60.64% | 7 | Mar 18, 2024 | |
| KZR Kezar Life Sciences | Reiterates: Buy | $20 | $0.80 | +2,384.78% | 11 | Mar 15, 2024 | |
| SPRB Spruce Biosciences | Downgrades: Neutral | n/a | $0.70 | - | 8 | Mar 14, 2024 | |
| BWAY BrainsWay | Maintains: Buy | $12 → $13 | $4.76 | +173.11% | 13 | Mar 11, 2024 | |
| CDXC ChromaDex | Maintains: Buy | $5 → $6 | $3.44 | +74.42% | 11 | Mar 11, 2024 | |
| CRDF Cardiff Oncology | Maintains: Buy | $12 → $14 | $4.07 | +243.98% | 11 | Mar 6, 2024 | |
| BBIO BridgeBio Pharma | Reiterates: Buy | $47 | $24.88 | +88.91% | 6 | Mar 4, 2024 | |
| VRNA Verona Pharma | Reiterates: Buy | $32 | $15.47 | +106.85% | 13 | Mar 4, 2024 | |
| ACRS Aclaris Therapeutics | Downgrades: Neutral | n/a | $1.20 | - | 11 | Jan 22, 2024 | |
| TARO Taro Pharmaceutical Industries | Downgrades: Neutral | $43 | $42.40 | +1.42% | 8 | Jan 18, 2024 | |
| CING Cingulate | Maintains: Buy | $3.5 → $8 | $0.88 | +808.99% | 3 | Jan 5, 2024 | |
| AVXL Anavex Life Sciences | Maintains: Buy | $54 → $40 | $3.44 | +1,062.79% | 14 | Jan 3, 2024 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $10 | $3.45 | +189.86% | 9 | Dec 11, 2023 | |
| SCLX Scilex Holding Company | Reiterates: Buy | $12 | $0.88 | +1,262.86% | 2 | Dec 4, 2023 | |
| PXMD PaxMedica | Initiates: Buy | $3 | $0.74 | +305.52% | 1 | Dec 4, 2023 | |
| LGVN Longeveron | Initiates: Buy | $60 | $1.75 | +3,328.57% | 1 | Dec 4, 2023 | |
| PLX Protalix BioTherapeutics | Reiterates: Buy | $10 | $1.15 | +769.57% | 4 | Nov 14, 2023 | |
| SLGL Sol-Gel Technologies | Maintains: Buy | $12 → $9 | $0.89 | +911.69% | 13 | Nov 13, 2023 | |
| AEZS Aeterna Zentaris | Maintains: Buy | $28 → $15 | $1.95 | +669.23% | 8 | Nov 13, 2023 | |
| BCPC Balchem | Maintains: Buy | $165 → $135 | $139.26 | -3.06% | 12 | Oct 30, 2023 | |
| PYPD PolyPid | Initiates: Buy | $16 | $4.75 | +236.66% | 1 | Oct 12, 2023 | |
| GLTO Galecto | Downgrades: Neutral | n/a | $0.70 | - | 5 | Sep 28, 2023 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $9 → $7 | $0.58 | +1,098.22% | 2 | Sep 25, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Buy | $6 | $2.70 | +121.93% | 2 | Sep 25, 2023 | |
| GRTX Galera Therapeutics | Downgrades: Neutral | $6 → $0.3 | $0.19 | +61.20% | 6 | Aug 16, 2023 | |
| ORMP Oramed Pharmaceuticals | Downgrades: Neutral | n/a | $2.46 | - | 3 | Jan 17, 2023 | |
| EVFM Evofem Biosciences | Maintains: Buy | $250 → $500 | $0.02 | +2,984,974.63% | 6 | Aug 15, 2022 | |
| ADXN Addex Therapeutics | Downgrades: Neutral | n/a | $16.10 | - | 4 | Jun 23, 2022 | |
| TYRA Tyra Biosciences | Initiates: Buy | $12 | $15.67 | -23.42% | 1 | Jun 23, 2022 | |
| NBSE NeuBase Therapeutics | Maintains: Buy | $300 → $200 | $0.44 | +45,395.91% | 3 | May 31, 2022 | |
| INM InMed Pharmaceuticals | Initiates: Buy | n/a | $0.23 | - | 1 | Nov 29, 2021 | |
| ABEO Abeona Therapeutics | Maintains: Buy | n/a | $3.26 | - | 3 | Nov 29, 2021 | |
| OMER Omeros | Maintains: Buy | n/a | $3.15 | - | 4 | Oct 19, 2021 | |
| SYBX Synlogic | Maintains: Buy | n/a | $1.87 | - | 2 | Oct 13, 2021 | |
| RDHL RedHill Biopharma | Maintains: Buy | n/a | $0.43 | - | 2 | Sep 15, 2021 | |
| IMUX Immunic | Maintains: Buy | n/a | $1.22 | - | 3 | Sep 7, 2021 | |
| XCUR Exicure | Maintains: Buy | n/a | $0.50 | - | 1 | May 17, 2021 | |
| RGEN Repligen | Maintains: Buy | n/a | $166.58 | - | 5 | May 5, 2021 | |
| BHC Bausch Health Companies | Maintains: Buy | n/a | $8.71 | - | 4 | Mar 16, 2021 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $775 → $925 | $2.92 | +31,561.82% | 2 | Mar 5, 2021 | |
| NRBO NeuroBo Pharmaceuticals | Maintains: Buy | $4,800 → $3,840 | $3.14 | +122,192.99% | 2 | Feb 1, 2021 | |
| CDNA CareDx | Maintains: Buy | n/a | $7.56 | - | 3 | Aug 5, 2020 | |
| APDN Applied DNA Sciences | Maintains: Buy | n/a | $4.37 | - | 2 | Jul 20, 2020 | |
| CYDY CytoDyn | Downgrades: Neutral | n/a | $0.14 | - | 1 | Jul 6, 2020 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $6.42 | - | 1 | Jul 1, 2020 | |
| IGMS IGM Biosciences | Initiates: Buy | n/a | $9.40 | - | 1 | Jul 1, 2020 | |
| INO Inovio Pharmaceuticals | Downgrades: Neutral | n/a | $10.57 | - | 3 | Jun 29, 2020 | |
| EVOK Evoke Pharma | Upgrades: Buy | n/a | $0.46 | - | 2 | Jun 22, 2020 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $17.53 | - | 1 | Mar 23, 2020 | |
| SWTX SpringWorks Therapeutics | Upgrades: Buy | n/a | $45.53 | - | 1 | Mar 19, 2020 | |
| CELC Celcuity | Initiates: Buy | n/a | $15.92 | - | 1 | Nov 20, 2018 | |
| CTMX CytomX Therapeutics | Initiates: Buy | n/a | $1.59 | - | 1 | Sep 13, 2018 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | n/a | $6.30 | - | 1 | Aug 24, 2018 | |
| CRMD CorMedix | Maintains: Buy | n/a | $5.31 | - | 1 | May 23, 2018 | |
| CHEK Check-Cap | Maintains: Buy | n/a | $2.29 | - | 1 | May 23, 2018 | |
| TTOO T2 Biosystems | Maintains: Buy | $40,000 → $42,500 | $2.84 | +1,496,378.87% | 2 | Mar 29, 2018 | |
| DRRX DURECT | Upgrades: Buy | n/a | $0.93 | - | 3 | Mar 6, 2018 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | n/a | $30.57 | - | 3 | Mar 5, 2018 | |
| AEMD Aethlon Medical | Initiates: Buy | n/a | $1.36 | - | 1 | Nov 20, 2017 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $18,000 → $6,000 | $2.68 | +223,780.60% | 1 | Nov 13, 2017 | |
| IMRN Immuron | Initiates: Buy | n/a | $2.64 | - | 1 | Oct 18, 2017 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $4.75 | - | 1 | Jul 26, 2017 | |
| ALIM Alimera Sciences | Initiates: Buy | n/a | $3.49 | - | 1 | Apr 27, 2017 |
Processa Pharmaceuticals
Apr 25, 2024
Initiates: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Gain Therapeutics
Apr 25, 2024
Reiterates: Buy
Price Target: $9
Current: $3.03
Upside: +197.03%
Enlivex Therapeutics
Apr 23, 2024
Reiterates: Buy
Price Target: $7
Current: $1.44
Upside: +386.11%
BioXcel Therapeutics
Apr 23, 2024
Reiterates: Buy
Price Target: $10
Current: $2.63
Upside: +280.23%
MoonLake Immunotherapeutics
Apr 23, 2024
Reiterates: Buy
Price Target: $100
Current: $42.49
Upside: +135.35%
Reviva Pharmaceuticals Holdings
Apr 22, 2024
Reiterates: Buy
Price Target: $20
Current: $2.99
Upside: +568.90%
UroGen Pharma
Apr 18, 2024
Reiterates: Buy
Price Target: $54
Current: $14.15
Upside: +281.63%
Microbot Medical
Apr 16, 2024
Maintains: Buy
Price Target: $8 → $7
Current: $0.88
Upside: +695.45%
Oncternal Therapeutics
Apr 15, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $8.29
Upside: +237.76%
Indaptus Therapeutics
Apr 15, 2024
Reiterates: Buy
Price Target: $12
Current: $2.44
Upside: +391.80%
RAPT Therapeutics
Apr 10, 2024
Reiterates: Neutral
Price Target: n/a
Current: $8.10
Upside: -
Arcadia Biosciences
Apr 5, 2024
Reiterates: Buy
Price Target: $10
Current: $2.09
Upside: +378.47%
Hoth Therapeutics
Apr 5, 2024
Reiterates: Buy
Price Target: $4
Current: $1.16
Upside: +244.83%
Aquestive Therapeutics
Apr 5, 2024
Reiterates: Buy
Price Target: $9
Current: $4.07
Upside: +121.13%
Genmab
Apr 4, 2024
Reiterates: Buy
Price Target: $50
Current: $28.15
Upside: +77.62%
Cocrystal Pharma
Apr 4, 2024
Reiterates: Buy
Price Target: $10
Current: $1.56
Upside: +543.09%
Fennec Pharmaceuticals
Apr 4, 2024
Maintains: Buy
Price Target: $17 → $18
Current: $9.21
Upside: +95.44%
Annovis Bio
Apr 2, 2024
Maintains: Buy
Price Target: $30
Current: $18.01
Upside: +66.57%
Equillium
Apr 2, 2024
Maintains: Buy
Price Target: $4 → $5
Current: $1.71
Upside: +192.40%
Entera Bio
Apr 2, 2024
Maintains: Buy
Price Target: $10
Current: $1.98
Upside: +405.05%
Axsome Therapeutics
Apr 2, 2024
Maintains: Buy
Price Target: $190
Current: $71.71
Upside: +164.96%
Landos Biopharma
Apr 1, 2024
Downgrades: Neutral
Price Target: $50 → $20
Current: $22.31
Upside: -8.47%
ADMA Biologics
Mar 26, 2024
Reiterates: Buy
Price Target: $6 → $7.5
Current: $6.55
Upside: +14.50%
Rockwell Medical
Mar 25, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.46
Upside: +518.56%
Regulus Therapeutics
Mar 25, 2024
Reiterates: Buy
Price Target: $9
Current: $2.42
Upside: +271.90%
Fate Therapeutics
Mar 19, 2024
Reiterates: Neutral
Price Target: $7
Current: $3.80
Upside: +84.21%
Spero Therapeutics
Mar 18, 2024
Reiterates: Buy
Price Target: $7
Current: $1.46
Upside: +379.45%
Entrada Therapeutics
Mar 18, 2024
Reiterates: Buy
Price Target: $20
Current: $12.45
Upside: +60.64%
Kezar Life Sciences
Mar 15, 2024
Reiterates: Buy
Price Target: $20
Current: $0.80
Upside: +2,384.78%
Spruce Biosciences
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.70
Upside: -
BrainsWay
Mar 11, 2024
Maintains: Buy
Price Target: $12 → $13
Current: $4.76
Upside: +173.11%
ChromaDex
Mar 11, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $3.44
Upside: +74.42%
Cardiff Oncology
Mar 6, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $4.07
Upside: +243.98%
BridgeBio Pharma
Mar 4, 2024
Reiterates: Buy
Price Target: $47
Current: $24.88
Upside: +88.91%
Verona Pharma
Mar 4, 2024
Reiterates: Buy
Price Target: $32
Current: $15.47
Upside: +106.85%
Aclaris Therapeutics
Jan 22, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Taro Pharmaceutical Industries
Jan 18, 2024
Downgrades: Neutral
Price Target: $43
Current: $42.40
Upside: +1.42%
Cingulate
Jan 5, 2024
Maintains: Buy
Price Target: $3.5 → $8
Current: $0.88
Upside: +808.99%
Anavex Life Sciences
Jan 3, 2024
Maintains: Buy
Price Target: $54 → $40
Current: $3.44
Upside: +1,062.79%
Eton Pharmaceuticals
Dec 11, 2023
Reiterates: Buy
Price Target: $10
Current: $3.45
Upside: +189.86%
Scilex Holding Company
Dec 4, 2023
Reiterates: Buy
Price Target: $12
Current: $0.88
Upside: +1,262.86%
PaxMedica
Dec 4, 2023
Initiates: Buy
Price Target: $3
Current: $0.74
Upside: +305.52%
Longeveron
Dec 4, 2023
Initiates: Buy
Price Target: $60
Current: $1.75
Upside: +3,328.57%
Protalix BioTherapeutics
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Sol-Gel Technologies
Nov 13, 2023
Maintains: Buy
Price Target: $12 → $9
Current: $0.89
Upside: +911.69%
Aeterna Zentaris
Nov 13, 2023
Maintains: Buy
Price Target: $28 → $15
Current: $1.95
Upside: +669.23%
Balchem
Oct 30, 2023
Maintains: Buy
Price Target: $165 → $135
Current: $139.26
Upside: -3.06%
PolyPid
Oct 12, 2023
Initiates: Buy
Price Target: $16
Current: $4.75
Upside: +236.66%
Galecto
Sep 28, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Ensysce Biosciences
Sep 25, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $0.58
Upside: +1,098.22%
Anebulo Pharmaceuticals
Sep 25, 2023
Reiterates: Buy
Price Target: $6
Current: $2.70
Upside: +121.93%
Galera Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: $6 → $0.3
Current: $0.19
Upside: +61.20%
Oramed Pharmaceuticals
Jan 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Evofem Biosciences
Aug 15, 2022
Maintains: Buy
Price Target: $250 → $500
Current: $0.02
Upside: +2,984,974.63%
Addex Therapeutics
Jun 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.10
Upside: -
Tyra Biosciences
Jun 23, 2022
Initiates: Buy
Price Target: $12
Current: $15.67
Upside: -23.42%
NeuBase Therapeutics
May 31, 2022
Maintains: Buy
Price Target: $300 → $200
Current: $0.44
Upside: +45,395.91%
InMed Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.23
Upside: -
Abeona Therapeutics
Nov 29, 2021
Maintains: Buy
Price Target: n/a
Current: $3.26
Upside: -
Omeros
Oct 19, 2021
Maintains: Buy
Price Target: n/a
Current: $3.15
Upside: -
Synlogic
Oct 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.87
Upside: -
RedHill Biopharma
Sep 15, 2021
Maintains: Buy
Price Target: n/a
Current: $0.43
Upside: -
Immunic
Sep 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.22
Upside: -
Exicure
May 17, 2021
Maintains: Buy
Price Target: n/a
Current: $0.50
Upside: -
Repligen
May 5, 2021
Maintains: Buy
Price Target: n/a
Current: $166.58
Upside: -
Bausch Health Companies
Mar 16, 2021
Maintains: Buy
Price Target: n/a
Current: $8.71
Upside: -
TFF Pharmaceuticals
Mar 5, 2021
Maintains: Buy
Price Target: $775 → $925
Current: $2.92
Upside: +31,561.82%
NeuroBo Pharmaceuticals
Feb 1, 2021
Maintains: Buy
Price Target: $4,800 → $3,840
Current: $3.14
Upside: +122,192.99%
CareDx
Aug 5, 2020
Maintains: Buy
Price Target: n/a
Current: $7.56
Upside: -
Applied DNA Sciences
Jul 20, 2020
Maintains: Buy
Price Target: n/a
Current: $4.37
Upside: -
CytoDyn
Jul 6, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.14
Upside: -
Replimune Group
Jul 1, 2020
Downgrades: Neutral
Price Target: n/a
Current: $6.42
Upside: -
IGM Biosciences
Jul 1, 2020
Initiates: Buy
Price Target: n/a
Current: $9.40
Upside: -
Inovio Pharmaceuticals
Jun 29, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.57
Upside: -
Evoke Pharma
Jun 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.46
Upside: -
BioLife Solutions
Mar 23, 2020
Maintains: Buy
Price Target: n/a
Current: $17.53
Upside: -
SpringWorks Therapeutics
Mar 19, 2020
Upgrades: Buy
Price Target: n/a
Current: $45.53
Upside: -
Celcuity
Nov 20, 2018
Initiates: Buy
Price Target: n/a
Current: $15.92
Upside: -
CytomX Therapeutics
Sep 13, 2018
Initiates: Buy
Price Target: n/a
Current: $1.59
Upside: -
Kala Pharmaceuticals
Aug 24, 2018
Maintains: Buy
Price Target: n/a
Current: $6.30
Upside: -
CorMedix
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $5.31
Upside: -
Check-Cap
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $2.29
Upside: -
T2 Biosystems
Mar 29, 2018
Maintains: Buy
Price Target: $40,000 → $42,500
Current: $2.84
Upside: +1,496,378.87%
DURECT
Mar 6, 2018
Upgrades: Buy
Price Target: n/a
Current: $0.93
Upside: -
DENTSPLY SIRONA
Mar 5, 2018
Maintains: Neutral
Price Target: n/a
Current: $30.57
Upside: -
Aethlon Medical
Nov 20, 2017
Initiates: Buy
Price Target: n/a
Current: $1.36
Upside: -
Bio-Path Holdings
Nov 13, 2017
Maintains: Buy
Price Target: $18,000 → $6,000
Current: $2.68
Upside: +223,780.60%
Immuron
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $2.64
Upside: -
Ocular Therapeutix
Jul 26, 2017
Initiates: Buy
Price Target: n/a
Current: $4.75
Upside: -
Alimera Sciences
Apr 27, 2017
Initiates: Buy
Price Target: n/a
Current: $3.49
Upside: -